We Accept amex

Formerly known as Maylips.com

info@directdoctorsupply.com+1-800-325-7104

Logo Logo
Track delivery Wishlist
  • 0 $ 0.00
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KARISMA
    • LEMONBOTTLE
    • LANLUMA
    • LIPORASE®
    • MEDIDERMA®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
Logo Logo
Menu
Close
Wishlist
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • BOTULAX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INNOTOX®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KAIMAX
    • KARISMA
    • LEMONBOTTLE
    • LETYBO®
    • LANLUMA
    • LIPORASE®
    • LIZTOX®
    • MEDIDERMA®
    • MEDITOXIN®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NABOTA® (JEUVEAU®)
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • Re N Tox™
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
  • 0 $ 0.00
Direct Doctor SupplyProduct BrandsORTHOVISC®
Product Category
  • Anaesthetics (2)
  • Body Sculpting (4)
  • Botulinum Toxins (33)
  • Cannulas and Needles (13)
  • Cellular Rejuvenation (1)
  • Dermal Filler Removal (2)
  • Dermal Fillers (192)
  • Biostimulators (10)
  • HA Dermal Fillers (129)
  • Korean Dermal Fillers (28)
  • Polynucleotides (17)
  • Skinboosters (16)
  • Exosomes (1)
  • Eyelash Enhancers (1)
  • Fat Removal (3)
  • Gynecology (8)
  • IV Therapy (2)
  • Mesotherapy (23)
  • Orthopedic Injections (11)
  • Peels and Masks (23)
  • Peptides for Research (45)
  • Aesthetic & Cosmetic Peptides (1)
  • Brain, Cognitive & Nootropic Peptides (4)
  • Healing & Regenerative Peptides (6)
  • Immune & Thymic Peptides (4)
  • Longevity & Anti-Aging Peptides (7)
  • Muscle Growth & Performance Peptides (11)
  • Sexual Health & Hormonal Peptides (3)
  • Weight Loss & Metabolic Peptides (11)
  • PRP Kits (1)
  • Skincare (26)
  • Threads (28)
  • PCLA Threads (3)
  • PDO Threads (20)
  • PLA Threads (3)
  • Weight Loss (24)
Product Brand
  • ALIAXIN® (6)
  • ALIDYA™ (1)
  • AQUALYX® (1)
  • AZZALURE® (1)
  • BCN (12)
  • BELLAST® (3)
  • BELOTERO® (7)
  • BIOMEDICO (3)
  • BIOREPEELCL3® (2)
  • BOCOUTURE® (XEOMIN®) (3)
  • BOTOX® (6)
  • CAREGEN (2)
  • CINGAL® (1)
  • CRESPINE® (1)
  • CROMA (4)
  • CYTOCARE (4)
  • DEPO-PROVERA® (1)
  • DERMALAX™ (3)
  • DESIRIAL® (2)
  • DUROLANE® (1)
  • DYSPORT® (4)
  • EJAL (1)
  • ELLANSÉ™ (2)
  • EMLA™ (2)
  • EUFLEXXA® (1)
  • EXOJUV (1)
  • FILLMED® (14)
  • FILORGA® (2)
  • GARDASIL® (1)
  • HArmonyCA™ (1)
  • HYACORP (5)
  • HYAFILIA® (2)
  • HYALGAN® (1)
  • HYMOVIS® (1)
  • HYNIDASE® (1)
  • INTRALINE® (24)
  • JALUPRO® (5)
  • JAYDESS® (1)
  • JUVÉDERM® (13)
  • KARISMA (1)
  • LANLUMA (1)
  • LEMONBOTTLE (1)
  • LIPORASE® (1)
  • MEDIDERMA® (26)
  • MESO-RELLE® (2)
  • MESOESTETIC® (2)
  • MICRONJET™ (1)
  • MIRENA® (1)
  • MONOVISC® (1)
  • MOUNJARO® (9)
  • NEAUVIA™ (11)
  • NEURAMIS® (1)
  • NEXPLANON® (2)
  • NITHYA (3)
  • NOVERA COMPOUNDS (46)
  • NUCLEOFILL™ (8)
  • ORTHOVISC® (1)
  • OZEMPIC® (8)
  • PERFECTHA® (4)
  • PLASMOLIFTING™ (1)
  • PLINEST® (5)
  • PROFHILO® (3)
  • ​PROSTROLANE® (1)
  • PRX-T33® (1)
  • RADIESSE® (3)
  • RAINBOW (7)
  • REFINE (3)
  • REJURAN® (3)
  • REJUVANAD+ (2)
  • RENEFIL (3)
  • RESTYLANE® (10)
  • REVANESSE® (6)
  • REVOFIL (9)
  • REVOLAX™ (4)
  • SAXENDA® (1)
  • SAYPHA® (6)
  • SCULPTRA® (1)
  • SESDERMA® (10)
  • SILHOUETTE (3)
  • SMB® (1)
  • SOFTFIL® (6)
  • STYLAGE® (25)
  • SUNEKOS® (4)
  • SUPARTZ® (1)
  • SYNVISC® (2)
  • T-SAFE® (1)
  • TEOSYAL® (12)
  • ​THERASET® (1)
  • ULTRA V® (1)
  • VISCODERM® (2)
  • WEGOVY® (6)
  • XEOMEEN® (1)
  • XEOMIN® (4)
  • ZO® (3)

Buy ORTHOVISC®

Showing the single result

Sort By:
  • ORTHOVISC 2ML ENGLISH 01ORTHOVISC 2ML ENGLISH 01
    ORTHOVISC®
    $ 52.00
    Add To Cart
    -+

ORTHOVISC® is a clinically established viscosupplement developed by Anika Therapeutics, Inc., formulated with ultra-high-molecular-weight (MW) hyaluronic acid derived from bacterial fermentation rather than avian tissue. Delivered as a course of consecutive weekly intra-articular injections into the knee joint per the approved regimen, ORTHOVISC® is designed to restore the viscoelastic properties of synovial fluid in patients with knee osteoarthritis. Direct Doctors Supply has served as a trusted wholesale supplier of ORTHOVISC® and orthopedic injectables for licensed practitioners since 2014. Browse the catalog below to order ORTHOVISC® for your practice.

ORTHOVISC® Product Range

Anika Therapeutics offers a complementary line of HA viscosupplements that allows practitioners to match the treatment format to individual patient needs and scheduling requirements.

ORTHOVISC® (30 mg/2 mL, three weekly injections) is the multi-injection option in the Anika range. Each single-use intra-articular syringe delivers 30 mg of ultra-high-MW sodium hyaluronate (15 mg/mL) in 2 mL of physiological saline, administered as a single injection at each weekly visit [3][4]. The FDA-approved ORTHOVISC® dosage regimen consists of three consecutive weekly injections. Some clinicians have historically used four-injection schedules, though the formally approved course per the PMA and IFU is three injections [3]. The treatment cycle is per affected knee; bilateral treatment requires a separate syringe for each knee [3]. Controlled clinical trials have demonstrated statistically significant improvements in WOMAC pain scores and patient global assessments compared with arthrocentesis control [1][2].

For patients or clinical settings where a single-visit format is preferred, Anika Therapeutics also produces MONOVISC®, whose treatment consists of one injection rather than the weekly ORTHOVISC® series, delivered using the same bacterial fermentation-derived high-MW sodium hyaluronate [4]. This MONOVISC® vs ORTHOVISC® relationship gives practices flexibility on scheduling within one manufacturer’s range.

About ORTHOVISC® — A Clinically Established Viscosupplementation Option

ORTHOVISC® is a viscosupplement manufactured by Anika Therapeutics, Inc., a US-based medical technology company specializing in joint preservation and musculoskeletal therapies. The product received Premarket Approval (PMA P030019) from the FDA on February 4, 2004, and is classified as a Class III medical device for the intra-articular treatment of pain associated with knee osteoarthritis [3]. As an FDA-approved treatment delivered by medical device rather than a pharmaceutical product, it provides practitioners with a non-pharmacologic option supported by a substantial body of controlled clinical evidence [1][2][3].

ORTHOVISC®’s ultra-high-molecular-weight sodium hyaluronate formulation and bacterial fermentation manufacturing process distinguish it in the viscosupplementation market. Anika Therapeutics, the ORTHOVISC® manufacturer, maintains a broad HA portfolio that includes ORTHOVISC®, the single-injection MONOVISC®, and CINGAL®, reflecting the company’s long-standing focus on hyaluronic acid-based joint therapies and regulatory-validated clinical development [3][4].

Ultra-High Molecular Weight HA — The Science Behind the ORTHOVISC® Injection

Hyaluronic acid is a naturally occurring component of synovial fluid, functioning as both a lubricant and shock absorber during joint movement. In osteoarthritis, both the concentration and molecular weight of endogenous HA decline, reducing the fluid’s viscoelastic properties and contributing to joint pain and stiffness [3][4].

ORTHOVISC® is a sterile, non-pyrogenic viscosupplement containing sodium hyaluronate at 15 mg/mL in physiological saline, with a molecular weight range of 1.0 to 2.9 million Daltons [3][4]. This ultra-high molecular weight profile supports enhanced lubricating and shock-absorbing capacity within the joint environment, as characterized in the product’s regulatory documentation [3][4].

ORTHOVISC® contains no corticosteroids [3]. Unlike steroid injections, which act through anti-inflammatory pharmacological pathways, ORTHOVISC® works by supplementing and restoring the mechanical properties of synovial fluid. Practitioners asking what ORTHOVISC® is made of can note that it is produced from ultra-high-molecular-weight sodium hyaluronate through bacterial fermentation at a concentration of 15 mg/mL [3][4].

The non-avian bacterial fermentation process removes the avian protein content present in rooster comb-derived products. The IFU nonetheless retains an avian-allergy caution, so the labeling should be checked before treating patients with known egg, feather, or poultry allergies [3][4].

Clinical Indications — Which Patients Are Candidates for ORTHOVISC® Treatment?

ORTHOVISC® is indicated for knee osteoarthritis pain in patients who have not achieved adequate relief from conservative measures, including physical therapy, activity modification, and simple analgesics [3]. It is approved specifically for use in the knee joints and is not indicated for other joints per its labeled indication [3].

Candidates for ORTHOVISC® treatment typically present with persistent knee pain, stiffness, and reduced mobility despite non-pharmacologic management. Viscosupplementation is often considered for patients seeking to postpone knee replacement surgery or those who are not yet appropriate surgical candidates.

Clinical data suggest that hyaluronic acid injections may be associated with longer time to knee arthroplasty in some patients with osteoarthritis, though this reflects an observed association rather than established causation [5]. Patient selection should be guided by clinical evaluation, symptom severity, and the degree of response to prior conservative treatment.

Why Healthcare Professionals Choose ORTHOVISC® for Knee Viscosupplementation

  • Ultra-High Molecular Weight Profile: Operating at 1.0 to 2.9 million Daltons, ORTHOVISC® sits at the higher end of the HA molecular weight spectrum among FDA-approved knee OA viscosupplements [3][4]. The viscoelastic properties of the injected fluid directly determine its capacity to function as a lubricant and shock absorber within the joint, and ORTHOVISC®’s ultra-high MW formulation is designed to more closely approximate the mechanical characteristics of healthy synovial fluid [3][4].
  • Bacterial Fermentation Origin: Because ORTHOVISC® is produced through bacterial fermentation rather than avian extraction, it does not contain avian-derived protein [3][4]. This broadens the eligible patient population without requiring avian allergy screening as part of the pre-treatment workup. That is a practical clinical advantage in high-volume orthopedic and sports medicine settings, where a health care professional may regularly buy orthopedic injections across multiple product categories.

Administration, Protocol, and What to Expect From ORTHOVISC® Shots

ORTHOVISC® is administered as an intra-articular injection into the knee joint using aseptic technique, by a healthcare professional trained in accepted intra-articular injection procedures [3]. The FDA-approved ORTHOVISC® treatment cycle consists of three consecutive weekly injections. Some clinicians have historically used a four-injection schedule, but the formally approved regimen per the PMA and IFU is three injections [3]. Each syringe is used for a single treatment session in a single knee only; bilateral treatment requires a separate syringe for each knee [3].

Before each injection, any joint effusion should be aspirated [3]. Among the special treatment instructions in the labeling, quaternary ammonium salt-containing skin disinfectants should be avoided during preparation, as these can precipitate hyaluronic acid [3]. Patients should be advised to avoid strenuous or prolonged weight-bearing activity for approximately 48 hours after each shot [3].

Because ORTHOVISC® shots are given as a series rather than a single dose, the timeline matters when setting patient expectations. Some report relief after the first injection, but for most, pain treatment with ORTHOVISC® builds gradually across the series and may continue in the weeks following the final shot [1][2]. Localized reactions at the injection site, including transient pain, swelling, and warmth, are generally short-lived and typically resolve within a few days [1][3].

About the Manufacturer — Anika Therapeutics

Anika Therapeutics, Inc. is a US-based global medical technology company focused on joint preservation and regenerative medicine. Its hyaluronic acid franchise spans ORTHOVISC®, the single-injection MONOVISC®, and CINGAL®, establishing both breadth of portfolio and depth of experience in HA-based joint therapies [3][4]. The company’s development approach centers on regulatory compliance and clinical validation, with its viscosupplement line supported by controlled trial data and long-standing FDA clearances [1][2][3].

ORTHOVISC® vs Competing Viscosupplementation Products

ORTHOVISC® vs EUFLEXXA®

Both ORTHOVISC® and EUFLEXXA® are non-avian HA products produced through bacterial fermentation [3][4]. The principal distinction lies in molecular weight: ORTHOVISC® operates at 1.0 to 2.9 million Daltons, while EUFLEXXA® is a non-cross-linked HA at a lower molecular weight [3]. Both are typically administered over three weekly injections, though their viscoelastic profiles and concentration specifications differ. Clinics that buy EUFLEXXA® alongside ORTHOVISC® can run the two side by side across comparable patients before standardizing on one.

ORTHOVISC® vs MONOVISC®

ORTHOVISC® and MONOVISC® share the same manufacturer and the same fermentation-derived ultra-high MW sodium hyaluronate source [4]. The key clinical differentiator is the injection schedule: ORTHOVISC® is administered over three consecutive weekly injections per the approved regimen, while MONOVISC® delivers an equivalent HA dose in a single intra-articular injection [3][4]. For a practice weighing visit burden against dosing familiarity, the option to buy MONOVISC® from the same catalog keeps both formats under one supplier and one ordering workflow.

ORTHOVISC® vs SYNVISC®

SYNVISC® (hylan G-F 20) is derived from avian tissue and is a cross-linked preparation combining hylan A and hylan B polymers [3]. ORTHOVISC® is a non-avian, non-cross-linked, ultra-high-MW sodium hyaluronate produced through bacterial fermentation. Practitioners should note that while ORTHOVISC® is bacterially derived, the IFU still advises clinical review for patients with avian sensitivities; avian allergy is a more direct concern with SYNVISC® given its rooster-comb origin [3][4]. Clinics that buy SYNVISC® for cross-linked avian protocols can order it from the same Direct Doctors Supply catalog.

ORTHOVISC® vs HYALGAN®

HYALGAN® is a lower-molecular-weight avian-derived HA product typically administered over five weekly injections, compared with ORTHOVISC®’s three-injection approved course [3]. ORTHOVISC® offers the advantages of ultra-high molecular weight and a non-avian bacterial fermentation source. Practices that value HYALGAN®’s longer clinical history and its avian-derived formulation can buy HYALGAN® for direct comparison with ORTHOVISC®.

ORTHOVISC® vs SUPARTZ®

SUPARTZ® is an avian-derived sodium hyaluronate product with a molecular weight range substantially below that of ORTHOVISC® (1.0 to 2.9 million Daltons), and it typically requires five weekly injections per treatment course [3]. Practitioners deciding between the two may weigh molecular weight, injection frequency, and avian origin against their patient population’s needs. The Direct Doctors Supply support team can confirm current availability for anyone looking to buy SUPARTZ® for their orthopedic inventory.

ORTHOVISC® Safety Profile — Side Effects and Contraindications

ORTHOVISC® has a well-characterized safety profile supported by randomized clinical trials [1][2][3]. Most adverse events are mild, temporary, and localized to the injection site. Common reactions include transient pain, swelling, warmth, and localized discomfort following intra-articular administration [3]. Clinical studies reported a low incidence of injection-site reactions comparable to that observed in saline-treated control patients [1][3].

ORTHOVISC® is contraindicated in patients with known hypersensitivity to hyaluronate preparations [3]. Although ORTHOVISC® is produced by bacterial fermentation and does not contain avian protein, the IFU retains a caution regarding patients with known allergies to avian-derived products, including eggs, feathers, or poultry [3][4]. Practitioners should review the full IFU and apply clinical judgment before treating patients with known or suspected sensitivities to avian agents.

ORTHOVISC® is also contraindicated in patients with active skin infections or disease at the intended injection site [3]. Transient increases in joint inflammation and rare allergic reactions have been reported; healthcare professionals should follow the manufacturer’s instructions for use in full before administering ORTHOVISC® [3].

ORTHOVISC® Regulatory Status and Medicare Coverage

ORTHOVISC® received Premarket Approval from the FDA on February 4, 2004, under PMA P030019 [3]. It is classified as a Class III medical device and approved for the treatment of pain associated with knee osteoarthritis in patients who have not achieved adequate relief with conservative non-pharmacologic therapies and simple analgesics [3]. The approval was supported by data from two randomized controlled studies establishing the product’s safety and effectiveness for its labeled indication [3].

For practitioners asking whether Medicare covers ORTHOVISC® injections, Medicare Part B coverage may be available for intra-articular hyaluronic acid injections for knee osteoarthritis when the applicable Local Coverage Determination (LCD) criteria are met. Coverage is not automatic and depends on individual patient eligibility, use of an FDA-approved product per its labeled dosing, and compliance with the local MAC’s current LCD requirements. Reimbursement and any patient out-of-pocket ORTHOVISC® injection cost therefore vary by payer and region, so practitioners should verify per-patient eligibility and consult their MAC’s current policy.

Distribution and Where to Source ORTHOVISC®

ORTHOVISC® is distributed across the United States and in international markets where regulatory clearance is in place. Licensed practitioners and clinic procurement teams should confirm local regulatory status and distributor authorization before ordering.

Direct Doctors Supply has operated as a dedicated wholesale supplier of orthopedic and aesthetic injectable medical devices since 2014. To order ORTHOVISC® wholesale, browse the Direct Doctors Supply catalog above or contact the support team directly. When buying online through Direct Doctors Supply, licensed practitioners benefit from a streamlined professional ordering process, competitive wholesale pricing, and reliable shipping. Practitioners who want to check for wholesale buying options or to purchase ORTHOVISC® online for their practice will find the Direct Doctors Supply platform built for clinical procurement.

Multi-specialty practices can also buy dermal fillers and buy hyaluronic acid dermal fillers through Direct Doctors Supply alongside their orthopedic orders.

Buy ORTHOVISC® Wholesale Through Direct Doctors Supply

Direct Doctors Supply supplies ORTHOVISC® to qualified, licensed practitioners and clinic procurement teams only. Before you buy ORTHOVISC® online, sourcing from a supplier with verifiable purity documentation, LOT number traceability, and a certificate of analysis protects both patient safety and regulatory standing, so confirm these are available before accepting any delivery. Direct Doctors Supply maintains an orthopedic injectables catalog with competitive wholesale pricing and temperature-appropriate shipping to preserve product integrity in transit. Reach out to the Direct Doctors Supply support team to confirm current availability and lead times.

FAQs

Is ORTHOVISC® a steroid?

No. ORTHOVISC® is a purified hyaluronic acid medical device, not a corticosteroid [3]. Its action is mechanical and biological. It supplements the viscoelastic properties of the synovial fluid rather than exerting a pharmacological anti-inflammatory effect. Patients comparing it to steroid injections should be counseled that the mechanism, onset, and duration of effect are different.

What is ORTHOVISC® made of?

ORTHOVISC® is composed of ultra-high-molecular-weight sodium hyaluronate (1.0 to 2.9 million Daltons) at a concentration of 15 mg/mL in physiological saline [3][4]. It is produced through bacterial fermentation rather than avian extraction, and does not contain avian-derived protein. Practitioners should still review the IFU for the full list of precautions before use [3].

What is ORTHOVISC® used for?

ORTHOVISC® is used for viscosupplementation in symptomatic knee osteoarthritis to restore the lubricating and shock-absorbing properties of synovial fluid [3]. It is indicated when conservative non-pharmacologic therapy and simple analgesics have not provided adequate relief, and is approved for the knee joint only [3].

How is ORTHOVISC® administered?

ORTHOVISC® is administered as an intra-articular knee injection by a trained healthcare professional, one dose per week across the approved three-injection course [3]. The clinician aspirates any effusion before injecting, and patients avoid strenuous weight-bearing for about 48 hours afterward. Full protocol notes are covered in the administration section above.

How long does it take for ORTHOVISC® to work?

Some patients report an early response to knee pain treatment after the first injection. The full therapeutic benefit typically builds over the ORTHOVISC® injection series and may continue to develop in the weeks following the final injection [1][2]. Individual results vary based on OA severity and patient-specific factors.

Is ORTHOVISC® a one-time injection?

No. A full ORTHOVISC® course runs across three weekly intra-articular injections rather than a single visit [3]. For patients who prefer a one-time option, the single-injection MONOVISC® from Anika Therapeutics is worth discussing [4].

How long do ORTHOVISC® side effects last?

Injection-site reactions, including transient pain and swelling, are generally short-lived and typically resolve within a few days after each ORTHOVISC® injection [1][3]. Serious adverse events are rare based on the controlled trial record [1][2].

What do ORTHOVISC® injection reviews indicate about its effectiveness?

Rather than relying on anecdotal ORTHOVISC® injection reviews, practitioners should weigh the controlled clinical evidence, which is the more reliable guide to effectiveness. In randomized trials, ORTHOVISC® produced statistically significant improvements in WOMAC pain scores and patient global assessments versus control [1][2]. Individual response still varies with OA severity and patient-specific factors, so trial averages describe the evidence base rather than any single expected outcome.

Does Medicare cover ORTHOVISC® injections?

Medicare Part B coverage may be available for intra-articular HA injections for knee OA when the applicable Local Coverage Determination criteria are met, including use of an FDA-approved product administered per its labeled dosing. Coverage is not automatic; practitioners should verify per-patient eligibility and consult their MAC’s current policy before treatment.

Looking to buy ORTHOVISC® products?

Direct Doctors Supply has supplied licensed practitioners with orthopedic injectables since 2014. The Direct Doctors Supply wholesale catalog offers ORTHOVISC® at competitive prices, with dedicated support staff, wholesale deals, and guaranteed delivery to hospitals, clinics, and healthcare facilities. To place a wholesale or individual order, browse the catalog above or reach out to the Direct Doctors Supply support team directly.

Citations and Resources about ORTHOVISC®

[1] Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT; ORTHOVISC Study Group. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. Clinical Orthopaedics and Related Research. 2001;(385):130–143. https://pubmed.ncbi.nlm.nih.gov/11302304/

[2] Neustadt D, Caldwell J, Bell M, Wade J, Gimbel J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. Journal of Rheumatology. 2005;32(10):1928–1936. https://pubmed.ncbi.nlm.nih.gov/16206349/

[3] U.S. Food and Drug Administration. ORTHOVISC® High Molecular Weight Hyaluronan — Summary of Safety and Effectiveness Data (PMA P030019). FDA. https://www.accessdata.fda.gov/cdrh_docs/pdf3/p030019c.pdf

[4] Anika Therapeutics, Inc. ORTHOVISC® — Product Information and Instructions for Use. Anika Therapeutics. https://anika.com/products/oapm/orthovisc/

[5] Ong KL, Anderson AF, Niazi F, Fierlinger AL, Kurtz SM, Altman RD. Hyaluronic acid injections in Medicare knee osteoarthritis patients are associated with longer time to knee arthroplasty. Journal of Arthroplasty. 2016;31:1667–1673. https://pubmed.ncbi.nlm.nih.gov/26895820/

All content on this website is intended for informational purposes and does not constitute medical advice.

Content prepared by Direct Doctor Supply’s editorial team.

Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.

SVG Logo Color cropped

info@directdoctorsupply.com

+1-800-325-7104

Book a MeetingTrack delivery
Trustpilot

Supported payment providers

Visa Mastercard American Express Google Pay Apple Pay

*Apple Pay and Google Pay are available via a personalized link provided by your account manager.

🔒 Transactions on this website meet strict PCI DSS compliance for your safety.

Product authenticity guaranteed: all products are sourced from licensed distributors and traceable by LOT number.

Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
  • Sitemap
Follow Us
  • Facebook
  • Instagram
  • LinkedIn
Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
Follow Us
  • Facebook
  • Instagram
  • Linkedin
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management

All peptide products sold by Direct Doctor Supply are Research Use Only (RUO) and intended solely for laboratory and scientific research. They are not FDA-approved and not for human or veterinary use, clinical, diagnostic, or therapeutic purposes. By purchasing RUO materials, you confirm they will be handled by qualified personnel in a proper research setting and in compliance with regulations. Products must not be administered to humans or animals or represented as safe or effective for medical use. Use is at your own risk; Direct Doctor Supply assumes no liability for misuse or regulatory issues.

2026 Direct Doctor Supply All rights reserved.
Terms Of Use Privacy Policy Refund and Replacement Shipping & Delivery